Edition:
India

People: Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

200.41USD
23 Sep 2019
Change (% chg)

$-0.02 (-0.01%)
Prev Close
$200.43
Open
$200.92
Day's High
$200.92
Day's Low
$199.50
Volume
5,240
Avg. Vol
62,677
52-wk High
$217.11
52-wk Low
$132.75

Vessey, Rupert 

Dr. Rupert J. Vessey, Ph.D. is Independent Director of the Company. Rupert Vessey, MA, BM BCh, FRCP, DPhil is currently the President of Global Research and Early Development at Celgene, and is anticipated to hold that position at Bristol-Myers Squibb once its acquisition of Celgene is final. Before joining Celgene, Dr. Vessey held various research and development senior management positions at Merck. Dr. Vessey holds an MA in physiological sciences and a BM BCh in clinical medicine from Oxford University where he completed his DPhil at the Institute for Molecular Medicine, Oxford along with additional clinical training at various hospitals in the UK. He is a member of the Royal College of Physicians of London UK.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Baumgartner

308,385

Charles Kummeth

9,664,870

James Hippel

2,448,890

Brenda Furlow

1,218,200

David Eansor

1,591,280

Robert Gavin

1,374,490
As Of  30 Jun 2018